3-Aminopyrrolidinone Farnesyltransferase Inhibitors: Design of Macrocyclic Compounds with Improved Pharmacokinetics and Excellent Cell PotencyIan M. Bell, C. Blair Zartman, Michelle Ellis-Hutchings et al.|Journal of Medicinal Chemistry|2002Cited by 86
Dual Protein Farnesyltransferase−Geranylgeranyltransferase-I Inhibitors as Potential Cancer Chemotherapeutic AgentsS. J. DESOLMS, Jeffrey S. Taylor, Terrence M. Ciccarone et al.|Journal of Medicinal Chemistry|2003Cited by 60
Design and Biological Activity of (<i>S</i>)-4-(5-{[1-(3-Chlorobenzyl)-2- oxopyrrolidin-3-ylamino]methyl}imidazol-1-ylmethyl)benzonitrile, a 3-Aminopyrrolidinone Farnesyltransferase Inhibitor with Excellent Cell PotencyIan M. Bell, Theresa M. Williams, Steven N. Gallicchio et al.|Journal of Medicinal Chemistry|2001Cited by 43
Potent inhibitors of farnesyltransferase and geranylgeranyltransferase-IDiem N. Nguyen, Carolyn A. Buser, Craig A. Stump et al.|Bioorganic & Medicinal Chemistry Letters|2002Cited by 22
Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferaseDouglas C. Beshore, Theresa M. Williams, Ian M. Bell et al.|Bioorganic & Medicinal Chemistry Letters|2001Cited by 5